Page last updated: 2024-10-31

metoprolol and Fibrosis, Inflammatory Perianeurysmal

metoprolol has been researched along with Fibrosis, Inflammatory Perianeurysmal in 3 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thompson, J1
Julian, DG1
Bullimore, DW1
Ahmad, S1

Other Studies

3 other studies available for metoprolol and Fibrosis, Inflammatory Perianeurysmal

ArticleYear
Retroperitoneal fibrosis associated with metoprolol.
    British medical journal (Clinical research ed.), 1982, Jan-09, Volume: 284, Issue:6309

    Topics: Humans; Male; Metoprolol; Middle Aged; Propanolamines; Retroperitoneal Fibrosis

1982
Retroperitoneal fibrosis associated with metoprolol.
    British medical journal (Clinical research ed.), 1982, Feb-27, Volume: 284, Issue:6316

    Topics: Humans; Metoprolol; Propanolamines; Retroperitoneal Fibrosis; Time Factors

1982
Association of metoprolol and retroperitoneal fibrosis.
    American heart journal, 1996, Volume: 131, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Constriction, Pathologic; Edema; Female

1996